Krystal Biotech, Inc. (KRYS)
276.45
+6.19
(+2.29%)
USD |
NASDAQ |
Feb 13, 16:00
276.80
+0.35
(+0.13%)
After-Hours: 20:00
Krystal Biotech Price : 276.45 for Feb. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.31 |
| DexCom, Inc. | 70.02 |
| Alkermes Plc | 33.16 |
| Regeneron Pharmaceuticals, Inc. | 803.17 |
| Alnylam Pharmaceuticals, Inc. | 314.40 |
Price Related Metrics
| PE Ratio | 41.47 |
| PS Ratio | 22.10 |
| PEG Ratio | 0.1496 |
| Price to Book Value | 7.045 |
| Price to Free Cash Flow | 49.81 |
| Earnings Yield | 2.41% |
| Market Cap | 8.016B |
| PEGY Ratio | 0.1496 |
| Operating PE Ratio | 52.12 |
| Normalized PE Ratio | 41.47 |